Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

438 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Executive summary of the Hellenic Atherosclerosis Society guidelines for the diagnosis and treatment of dyslipidemias - 2023.
Katsiki N, Filippatos T, Vlachopoulos C, Panagiotakos D, Milionis H, Tselepis A, Garoufi A, Rallidis L, Richter D, Nomikos T, Kolovou G, Kypreos K, Chrysohoou C, Tziomalos K, Skoumas I, Koutagiar I, Attilakos A, Papagianni M, Boutari C, Kotsis V, Pitsavos C, Elisaf M, Tsioufis K, Liberopoulos E. Katsiki N, et al. Among authors: vlachopoulos c. Atheroscler Plus. 2024 Feb 17;55:74-92. doi: 10.1016/j.athplu.2024.01.004. eCollection 2024 Mar. Atheroscler Plus. 2024. PMID: 38425675 Free PMC article. Review.
Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.
Achimastos A, Alexandrides T, Alexopoulos D, Athyros V, Bargiota A, Bilianou E, Chrysochoou C, Drogari E, Elisaf M, Ganotakis E, Goudevenos I, Ioannidis I, Kolovou G, Kotsis V, Lekakis I, Liberopoulos E, Melidonis A, Nikolaou V, Ntaios G, Papanas N, Pappas S, Pitsavos C, Rallidis L, Richter D, Skoumas I, Tentolouris N, Tousoulis D, Tselepis A, Tsioufis K, Tziakas D, Tziomalos K, Vardas P, Vlachopoulos C, Vlahakos D. Achimastos A, et al. Among authors: vlachopoulos c. Hormones (Athens). 2016 Jan-Mar;15(1):8-14. doi: 10.14310/horm.2002.1659. Hormones (Athens). 2016. PMID: 27086681 Free article.
Evolocumab use in Greece is associated with early and sustainable reductions in low-density cholesterol (LDL-C) and high persistence to therapy: Results from the Greek cohort analysis of the observational HEYMANS study.
Vlachopoulos C, Massia D, Kochiadakis G, Kolovou G, Patsilinakos S, Bridges I, Sibartie M, Dhalwani NN, Liberopoulos E, Ray KK. Vlachopoulos C, et al. Hellenic J Cardiol. 2023 Nov-Dec;74:74-76. doi: 10.1016/j.hjc.2023.09.003. Epub 2023 Sep 18. Hellenic J Cardiol. 2023. PMID: 37730147 Free article. No abstract available.
Prevalence and Risk Factors for Atherosclerotic Cardiovascular Disease in 7704 Individuals: An Analysis from the Greek Registry for the Prevalence of Familial Hypercholesterolemia (GRegistry-FH).
Kolovou G, Makrygiannis S, Marvaki C, Pavlatou N, Anagnostopoulou K, Giannakopoulou V, Goumas G, Kalogeropoulos P, Kolovou V, Limberi S, Perrea D, Tzenalis A, Emre Z, Jahaj E, Kasiara Z, Giannakoulis I, Tsolakoglou I, Kadda O, Tsaloukidis N, Koulaxidou R, Marvaki A, Foussas S, Melidonis A, Hoursalas G, Vlachopoulos C, Katsiki N, Milionis H, Liberopoulos E, Bilianou H. Kolovou G, et al. Among authors: vlachopoulos c. J Cardiovasc Dev Dis. 2024 Dec 23;11(12):411. doi: 10.3390/jcdd11120411. J Cardiovasc Dev Dis. 2024. PMID: 39728301 Free PMC article.
Prognostic Role of Functional SYNTAX Score Based on Quantitative Flow Ratio.
Terentes-Printzios D, Gkini KP, Oikonomou D, Gardikioti V, Aznaouridis K, Dima I, Tsioufis K, Vlachopoulos C. Terentes-Printzios D, et al. Among authors: vlachopoulos c. Biomedicines. 2024 Oct 24;12(11):2437. doi: 10.3390/biomedicines12112437. Biomedicines. 2024. PMID: 39595005 Free PMC article.
2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP).
Banach M, Reiner Ž, Surma S, Bajraktari G, Bielecka-Dabrowa A, Bunc M, Bytyçi I, Ceska R, Cicero AFG, Dudek D, Dyrbuś K, Fedacko J, Fras Z, Gaita D, Gavish D, Gierlotka M, Gil R, Gouni-Berthold I, Jankowski P, Járai Z, Jóźwiak J, Katsiki N, Latkovskis G, Magda SL, Margetic E, Margoczy R, Mitchenko O, Durak-Nalbantic A, Ostadal P, Paragh G, Petrulioniene Z, Paneni F, Pećin I, Pella D, Postadzhiyan A, Stoian AP, Trbusic M, Udroiu CA, Viigimaa M, Vinereanu D, Vlachopoulos C, Vrablik M, Vulic D, Penson PE; International Lipid Expert Panel (ILEP). Banach M, et al. Among authors: vlachopoulos c. Drugs. 2024 Dec;84(12):1541-1577. doi: 10.1007/s40265-024-02105-5. Epub 2024 Nov 4. Drugs. 2024. PMID: 39497020 Free PMC article.
A phenomap of TTR amyloidosis to aid diagnostic screening.
Antonopoulos AS, Tsampras T, Lazaros G, Tsioufis K, Vlachopoulos C. Antonopoulos AS, et al. Among authors: vlachopoulos c. ESC Heart Fail. 2024 Oct 31. doi: 10.1002/ehf2.15143. Online ahead of print. ESC Heart Fail. 2024. PMID: 39482264 Free article. Review.
The effect of lipid-lowering treatment on indices of MASLD in familial hypercholesterolemia patients.
Boutari C, Rizos CV, Liamis G, Skoumas I, Rallidis L, Garoufi A, Kolovou G, Sfikas G, Tziomalos K, Skalidis E, Kotsis V, Doumas M, Stamatelopoulos K, Lambadiari V, Anagnostis P, Boufidou A, Giannakopoulou V, Anastasiou G, Petkou E, Vlachopoulos C, Dima I, Fakas G, Papathanasiou KA, Attilakos A, Kolovou V, Koumaras C, Agapakis D, Zacharis E, Antza C, Milionis H, Liberopoulos E, Mantzoros CS. Boutari C, et al. Among authors: vlachopoulos c. Clin Nutr. 2024 Dec;43(12):84-91. doi: 10.1016/j.clnu.2024.10.020. Epub 2024 Oct 16. Clin Nutr. 2024. PMID: 39437569
438 results